1. Okt. 2019Ing. Dr. Birgit Flechl, PhD

ESMO 2019: Die Highlights für Radioonkologen

Ing. Dr. Birgit Flechl, PhD, MedAustron Wiener Neustadt, über Studien zu Nebenwirkungsmanagement, technischem Fortschritt und Zweitmalignome.

Inhalte im Video:
Interview von:
Produziert von:

Abstracts, die im Interview diskutiert werden:

  • ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
  • Poortmans P: Challenge your expert – Partial breast radiation therapy: Which patients, when, and with what technique?
  • Multidisciplinary session: WHO grade II and III gliomas: State of the art management.
  • Parker C et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): First results from the RADICALS RT randomised controlled trial (RCT). #LBA49_PR
  • Multidisciplinary session: Radiation-associated sarcoma
  • Keynote lecture: HPV vaccination for everybody?
  • Multidisciplinary session: Treatment of pelvic node-positive prostate cancer